Activity value 72china Supplier,Last transaction date:
2026-04-21
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for shanghai huilun pharmaceutical from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 4 transactions, with a transaction quantity of 0 and a transaction weight of 2.6.
Product description
PHARMACEUTICAL RAW MATERIAL ( CABOZANTINIB S-MALATE ) IN POWDER FORM ...BATCH NO A423005...MFG DATE 19-08-2025...EXPIRY DATE 07-2028...QUANTITY 01 GCiAaRfTQOeNQ.m.M.gN6E0T WEIGHT 0.153 KGS ...153 GM ....BRAND CRYSTAL /SHANGHAI...I/O CHINA SHIPMENT FROM UAE
Expand
shanghai huilun pharmaceutical is china Supplier,
and primarily engages in the import and export business of products such as pharmaceutical raw material,azacitidine,ticagrelor.
According to the 52wmb.com global trade database, as of 2026-04-21, the company has completed 52 international trades,
with its main trading regions covering pakistan,bangladesh,russia etc.
The core products include HS29335990,HS29420090,HS29339900 etc,
and its main trading partners are ооо технология лекарств,công ty cổ phần dược phẩm vĩnh phúc,beacon pharmaceuticals plc..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on shanghai huilun pharmaceutical is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.